Hexima scores with DuPont

By Dylan Bushell-Embling
Thursday, 07 August, 2008

Hexima [ASX: HXL] is to partner with chemical multinational DuPont to develop a fungal disease resistance technology in crops such as corn and soybeans.

Under the agreement Hexima and DuPont subsidiary Pioneer Hi-Breed will combine a series of intellectual properties to create the technology. Pioneer will use its gene-shuffling technology while Hexima will offer its gene delivery technology.

Pioneer will own commercialisation rights for corn and soybeans and Hexima will manage all other crops. The first target is broad-spectrum disease resistance in corn, especially stalk rot.

Pioneer has agreed to purchase a five per cent stake in Hexima, or four million shares, at a price of $1.50 per share.

Related News

Bacteriophage cocktail to combat superbugs

Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...

Exclusive colostrum intake may reduce risk of food allergies

Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...

Sunscreen and supplements can lower your vitamin D levels

People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd